Medical Insiders: Improving the Diagnosis and Management of Overactive Bladder in the Primary Care Setting
Symptoms of overactive bladder (OAB) are present in as many as ____ of American adults.
D. 30%. Nearly 1 in 3 US adults aged 40 years or older report symptoms of OAB at least sometimes. Despite this estimated prevalence, OAB remains vastly underrecognized and untreated.
Learn how to incorporate a guideline-based approach for the evaluation of lower urinary tract symptoms in this webcast by clicking the ‘Start’ button.
Milsom I, et al. Urology. 2012;80(1):90-6.
Matt T. Rosenberg, MD
Mid-Michigan Health Centers
David R. Staskin, MD
Associate Professor, Urology
Tufts University School of Medicine
St. Elizabeth’s Medical Center
Allison Gardner, PhD
Vice President, Educational Strategy and Content
Kathryn Schaefer, MSN, RN
Lead Nurse Planner
East Lansing, MI
Upon completion, participants should be able to:
- Incorporate a guideline-based approach for the evaluation of lower urinary tract symptoms
- Describe strategies to individualize evidence-based treatment plans for OAB in collaboration with patients
This activity is intended for primary care physicians.
Statement of Need
In many cases, overactive bladder (OAB) can be safely and effectively treated in primary care practice. Unfortunately, despite an estimated prevalence of almost 30% in the United States, OAB remains vastly underrecognized and untreated. Indeed, patients may neglect to discuss symptoms with their healthcare providers due to embarrassment or the misconception that their bladder issues are a normal part of aging, and primary care physicians may fail to ask patients with established risk factors about lower urinary tract symptoms, perhaps for the same reasons. Therefore, primary care clinicians would benefit from education on the diagnostic evaluation of patients with lower urinary tract symptoms and treatment strategies for patients with OAB who can be safely managed in this setting.
Provided by Med-IQ.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit
To receive credit, read the introductory CME material, watch the webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: December 22, 2017
Expiration Date: December 21, 2018
Estimated Time to Complete This Activity: 45 minutes
The evaluation, attestation, and post-test may be accessed by clicking the “Get Credit” tab at the bottom of the webcast activity.
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Matt T. Rosenberg, MD
Fees received for promotional/non-CME activities: Astellas Pharma US, Inc., OPKO Health Inc.
David R. Staskin, MD
Consulting fees/advisory boards: Aquinox, Astellas Pharma US, Inc.,
Contracted research: Aquinox, Astellas Pharma US, Inc., GTx, Inc.
The peer reviewers and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or email email@example.com.
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Google Chrome - latest version
Apple Safari - latest version
Adobe Acrobat Reader® or Adobe Reader
Adobe Flash Player
Adobe Flash Player 9 or later
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support.
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Astellas.
© 2017 Med-IQ, LLC
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.